Oligodendroglioma differential diagnosis

Oligodendroglioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Oligodendroglioma from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Staging
History & Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Oligodendroglioma differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Oligodendroglioma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Oligodendroglioma differential diagnosis
CDC on Oligodendroglioma differential diagnosis
Oligodendroglioma differential diagnosis in the news
Blogs on Oligodendroglioma differential diagnosis
Directions to Hospitals Treating Oligodendroglioma
Risk calculators and risk factors for Oligodendroglioma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Oligodendroglioma must be differentiated from:

Differentiating Oligodendroglioma from other Diseases

Oligodendroglioma must be differentiated from:

• Pilocytic astrocytoma
• Central neurocytoma, the so-called dysembryoplastic neuroepithelial tumor
• Ependymoma

(Their name derives from the Greek roots 'oligo' meaning “ few” and 'dendro' meaning “trees”.)

References

Template:WikiDoc Sources